GlassScriptPhysician profile
Leslie Gomez
NPI 1255699534
$2,863.77
in general payments reported to CMS, 2019-2025
29 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $73.58 · 2021: $509 · 2022: $574 · 2023: $610 · 2024: $665 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.84 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $310.89 | 2022-2024 | Austedo Xr, Austedo |
| Astrazeneca Pharmaceuticals LP | $291.64 | 2020-2024 | Airsupra, Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $268.99 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $260.28 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $231.04 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $182.01 | 2021-2023 | |
| Pfizer INC. | $161.95 | 2019-2025 | |
| Abbott Laboratories | $150.00 | 2024 | Mitraclip |
| Inari Medical, INC. | $141.70 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $125.68 | 2022-2025 | |
| Astellas Pharma US INC | $121.67 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.83 | 2019-2024 | |
| Otsuka America Pharmaceutical, INC. | $76.18 | 2022-2024 | Rexulti |
| Exact Sciences Corporation | $60.20 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $50.09 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $41.98 | 2021-2023 | Watchman Access System |
| Eisai INC. | $38.52 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $37.50 | 2022 | |
| Dexcom, INC. | $30.32 | 2022 | |
| Amgen INC. | $27.16 | 2024 | Evenity, Prolia |
| Amarin Pharma, INC. | $23.96 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.62 | 2023 | Crysvita |
| Mannkind Corporation | $19.01 | 2022 | |
| Biogen, INC. | $18.69 | 2021 | |
| Tactile Systems Technology INC | $17.54 | 2024 | Entre Plus, Flexitouch Plus |
| Shield Therapeutics INC | $15.88 | 2025 | |
| Allergan, INC. | $15.16 | 2020 | |
| Stryker Corporation | $14.84 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Aimmune Therapeutics, INC. | $14.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.